{"id":"https://openalex.org/W4385658486","doi":"https://doi.org/10.1097/01.hs9.0000967576.33522.1a","title":"S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION","display_name":"S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385658486","doi":"https://doi.org/10.1097/01.hs9.0000967576.33522.1a","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428326"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000967576.33522.1a","doi":"https://doi.org/10.1097/01.hs9.0000967576.33522.1a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000967576.33522.1a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000967576.33522.1a","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043227502","display_name":"Aristoteles A. N. Giagounidis","orcid":"https://orcid.org/0000-0003-4083-4109","observed_orcids":["https://orcid.org/0000-0003-4083-4109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aristoteles Giagounidis","raw_affiliation_strings":["Marien Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marien Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080661528","display_name":"Thomas Cluzeau","orcid":"https://orcid.org/0000-0002-6745-1127","observed_orcids":["https://orcid.org/0000-0002-6745-1127"]},"institutions":[{"id":"https://openalex.org/I3018988418","display_name":"Centre Hospitalier Universitaire de Nice","ror":"https://ror.org/05qsjq305","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thomas Cluzeau","raw_affiliation_strings":["Nice University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nice University Hospital","institution_ids":["https://openalex.org/I3018988418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063154849","display_name":"Mar\u00eda D\u00edez\u2010Campelo","orcid":"https://orcid.org/0000-0002-1467-6779","observed_orcids":["https://orcid.org/0000-0002-1467-6779","https://orcid.org/0000-0003-0386-4835"]},"institutions":[{"id":"https://openalex.org/I3018988418","display_name":"Centre Hospitalier Universitaire de Nice","ror":"https://ror.org/05qsjq305","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mar\u00eda D\u00edez Campelo","raw_affiliation_strings":["Hospital Universitario de Salamanca, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Nice, France","institution_ids":["https://openalex.org/I3018988418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047899373","display_name":"David M. Ross","orcid":"https://orcid.org/0000-0001-7171-2935","observed_orcids":["https://orcid.org/0000-0001-7171-2935"]},"institutions":[{"id":"https://openalex.org/I2802931750","display_name":"Flinders Medical Centre","ror":"https://ror.org/020aczd56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802931750"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David Ross","raw_affiliation_strings":["Flinders Medical Centre, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flinders Medical Centre, Adelaide, Australia","institution_ids":["https://openalex.org/I2802931750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061556384","display_name":"Lynette Chui Yen Chee","orcid":"https://orcid.org/0000-0002-4250-4448","observed_orcids":["https://orcid.org/0000-0002-4250-4448"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Lynette Chee","raw_affiliation_strings":["The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947429","display_name":"Shuh Ying Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087110","display_name":"St Vincent's Hospital Melbourne","ror":"https://ror.org/001kjn539","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087110","https://openalex.org/I4210098850"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shuhying Tan","raw_affiliation_strings":["St. Vincent\u2019s Hospital, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Vincent\u2019s Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I4210087110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026367659","display_name":"Christine Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Graham","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100690767","display_name":"Wei Feng","orcid":"https://orcid.org/0000-0002-8610-7372","observed_orcids":["https://orcid.org/0000-0002-8610-7372"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Feng","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101284884","display_name":"Ming Yang","orcid":"https://orcid.org/0009-0004-7814-1513","observed_orcids":["https://orcid.org/0009-0004-7814-1513","https://orcid.org/0009-0000-0357-0218"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ming Yang","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011979986","display_name":"Ying Jiang","orcid":"https://orcid.org/0000-0001-9800-6432","observed_orcids":["https://orcid.org/0000-0001-9800-6432"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Jiang","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055579461","display_name":"Miranda Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miranda Ross","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065670225","display_name":"Allie McGinty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allie Mcginty","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041302908","display_name":"Suresh Bobba","orcid":"https://orcid.org/0000-0002-8003-0634","observed_orcids":["https://orcid.org/0000-0002-8003-0634"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suresh Bobba","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025251645","display_name":"Christopher Rovaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Rovaldi","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simon Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simon Cooper","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063783158","display_name":"Jen L. Salstrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jen Salstrom","raw_affiliation_strings":["Keros Therapeutics, Lexington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, United States","institution_ids":["https://openalex.org/I4405259476"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e335221a","last_page":"e335221a"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.024700000882148743,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9409999847412109},{"id":"https://openalex.org/keywords/lower-risk-mds","display_name":"low-risk MDS","score":0.9160000085830688},{"id":"https://openalex.org/keywords/erythropoiesis","display_name":"erythropoiesis","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ring-sideroblasts","display_name":"ring sideroblasts","score":0.8519999980926514},{"id":"https://openalex.org/keywords/transfusion-burden","display_name":"transfusion burden","score":0.7699999809265137},{"id":"https://openalex.org/keywords/transfusion-independence","display_name":"transfusion independence","score":0.9599999785423279},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7289999723434448},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.6000000238418579},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.3140000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7978740930557251},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.5902859568595886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5849865674972534},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5778366923332214},{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.5658519268035889},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.5608354806900024},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5425863862037659},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5231263041496277},{"id":"https://openalex.org/C2780844101","wikidata":"https://www.wikidata.org/wiki/Q2380264","display_name":"Ineffective erythropoiesis","level":4,"score":0.48864299058914185},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4670003652572632},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4505780041217804},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.42585471272468567},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2159041464328766},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000967576.33522.1a","doi":"https://doi.org/10.1097/01.hs9.0000967576.33522.1a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000967576.33522.1a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10428326","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428326","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10428326/pdf/hs9-7-e335221a.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:35522dff0c1c4c19931f61a133084c1b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/35522dff0c1c4c19931f61a133084c1b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e335221a (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000967576.33522.1a","doi":"https://doi.org/10.1097/01.hs9.0000967576.33522.1a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000967576.33522.1a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385658486.pdf","grobid_xml":"https://content.openalex.org/works/W4385658486.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389247611","https://openalex.org/W4283718038","https://openalex.org/W3214625510","https://openalex.org/W3096118172","https://openalex.org/W4310114222","https://openalex.org/W4389220471","https://openalex.org/W4310104176","https://openalex.org/W3212754980","https://openalex.org/W3097030369","https://openalex.org/W4405035165"],"abstract_inverted_index":{"Background:":[0],"Myelodysplastic":[1,525],"syndromes":[2],"(MDS)":[3],"are":[4,163,207,219,275],"a":[5,479,494],"heterogeneous":[6],"group":[7],"of":[8,33,139,176,199,205,239,266,298,312,319,421,438,454],"bone":[9,35],"marrow":[10],"disorders":[11],"characterized":[12],"by":[13,63],"ineffective":[14],"hematopoiesis,":[15,504],"progressive":[16],"cytopenias":[17],"and":[18,71,96,100,102,117,130,141,154,174,190,252,291,293,300,314,348,386,419,466,474,497,513,516],"increasing":[19],"dependence":[20],"on":[21,115,445],"red":[22],"blood":[23],"cell":[24],"transfusions.":[25],"Greater":[26],"transfusion":[27,41,142,191,315,476],"burden":[28,42,477],"reflects":[29],"diminished":[30,329],"erythropoietic":[31,119,330],"capacity":[32,331],"the":[34,106,172,210,225,367,382,395,426,455,468,523],"marrow.":[36],"For":[37],"patients":[38,179],"with":[39,125,135,157,180,263,428,463],"high":[40],"(HTB),":[43],"currently":[44],"available":[45],"treatments":[46],"such":[47,65],"as":[48,66,238,453],"Erythropoiesis":[49],"Stimulating":[50],"Agents":[51,55],"or":[52,268,423],"Erythroid":[53],"Maturation":[54],"show":[56],"limited":[57],"efficacy.":[58],"Response":[59],"is":[60,77,511],"further":[61],"influenced":[62],"factors":[64],"endogenous":[67],"erythropoietin":[68],"(EPO)":[69],"level":[70],"ring":[72],"sideroblast":[73],"(RS)":[74],"status.":[75,143,316],"KER-050":[76,113,122,158,177,307,340,459,489],"an":[78,166],"investigational,":[79],"modified":[80],"activin":[81],"receptor":[82,322],"type":[83],"IIA":[84],"ligand":[85],"trap":[86],"designed":[87],"to":[88,105,308,333,379,470,501],"inhibit":[89],"select":[90],"TGF-\u03b2":[91,486],"superfamily":[92,487],"ligands":[93],"(activins":[94],"A":[95],"B,":[97],"GDFs":[98],"8":[99,195],"11)":[101],"restore":[103,493],"balance":[104],"osteohematopoietic":[107],"niche":[108],"(OHN).":[109],"In":[110,425],"preclinical":[111],"findings,":[112],"acted":[114],"early":[116],"late-stage":[118],"progenitors.":[120],"Clinically,":[121],"was":[123,260,460],"associated":[124],"increases":[126,345,406,416],"in":[127,133,148,178,277,343,346,353,361,366,373,407,417,434,478,506],"hematopoiesis":[128,149,200],"markers":[129,150,201],"hematological":[131,155,472],"responses":[132,156],"participants":[134,214,222,271,327,335,375,400],"lower-risk":[136,181,481],"MDS,":[137],"irrespective":[138],"RS":[140,313],"Aims:":[144],"To":[145],"characterize":[146],"changes":[147],"over":[151,194,202,350,381,409,491],"6":[152,203,351,412],"months":[153,204,352,413],"treatment":[159,206,258,341,465],"Methods:":[160],"Interim":[161],"results":[162,518],"presented":[164,208,220,276],"from":[165,221,448],"ongoing":[167,512],"Phase":[168,450],"2":[169,228,398,451],"study":[170,452],"evaluating":[171],"safety":[173,515],"tolerability":[175],"MDS.":[182],"Secondary":[183],"efficacy":[184,517],"endpoints":[185],"include":[186],"IWG":[187],"2006":[188],"HI-E":[189,267,299,354,422],"independence":[192],"(TI)":[193],"weeks.":[196],"Exploratory":[197],"evaluations":[198],"for":[209,306],"first":[211,383],"time.":[212],"All":[213],"provided":[215],"informed":[216],"consent.":[217],"Data":[218],"dosed":[223],"at":[224,410,522],"recommended":[226],"part":[227],"dose":[229],"(RP2D;":[230],"3.75":[231],"\u2013":[232],"5":[233],"mg/kg":[234],"every":[235],"4":[236],"weeks)":[237],"October":[240],"1,":[241],"2022.":[242],"Results:":[243],"The":[244,280],"RP2D":[245,368],"population":[246],"(N=36)":[247],"included":[248],"13":[249],"(36%)":[250],"non-RS":[251,326],"20":[253],"(56%)":[254],"HTB":[255,374,399],"participants.":[256],"Mean":[257],"duration":[259],"28":[261],"weeks,":[262],"79%":[264],"(23/29)":[265],"TI":[269,301,356],"evaluable":[270],"ongoing.":[272],"Safety":[273],"data":[274,456],"Table":[278],"1.":[279],"most":[281],"frequent":[282],"adverse":[283],"events":[284],"(AEs)":[285],"were":[286,363,371,387],"diarrhoea":[287],"(22%),":[288],"fatigue":[289],"(19%)":[290],"dyspnoea":[292],"nausea":[294],"(17%":[295],"each).":[296],"Rates":[297],"(Table":[302],"2)":[303],"demonstrated":[304],"potential":[305,469],"improve":[309],"anemia":[310],"regardless":[311],"Baseline":[317],"levels":[318],"soluble":[320],"transferrin":[321],"(sTfR)":[323],"indicated":[324],"that":[325,414],"showed":[328],"relative":[332],"RS+":[334],"(Fig.":[336,358,392,441],"1":[337],"A,":[338],"B).":[339],"resulted":[342],"sustained":[344,405],"hemoglobin":[347,418],"platelets":[349],"and/or":[355],"responders":[357],"2).":[359],"Increases":[360,370],"sTfR":[362,377],"also":[364],"observed":[365,432],"population.":[369,483],"greater":[372],"where":[376],"continued":[378],"rise":[380],"16":[384],"weeks":[385,391],"maintained":[388],"through":[389],"24":[390],"3).":[393],"At":[394],"individual":[396],"level,":[397],"(1":[401],"RS+,1":[402],"non-RS)":[403],"exhibited":[404],"sTFR":[408],"least":[411],"paralleled":[415],"periods":[420],"TI.":[424],"participant":[427],"elevated":[429],"baseline":[430],"ferritin,":[431],"decreases":[433],"ferritin":[435],"suggest":[436],"reduction":[437],"iron":[439,499],"overload":[440,500],"4).":[442],"Summary/Conclusion:":[443],"Based":[444],"interim":[446],"findings":[447],"this":[449],"cut-off":[457],"date,":[458],"generally":[461],"well-tolerated":[462],"longer-term":[464],"has":[467],"drive":[471],"improvement":[473],"reduce":[475,498],"broad,":[480],"MDS":[482],"By":[484],"modulating":[485],"ligands,":[488],"may":[490],"time":[492],"healthy":[495],"OHN":[496],"support":[502],"normal":[503],"even":[505],"heavily":[507],"transfused":[508],"patients.":[509],"Enrollment":[510],"updated":[514],"will":[519],"be":[520],"reported":[521],"meeting.Keywords:":[524],"syndrome,":[526],"Iron":[527],"overload,":[528],"Erythropoieisis,":[529],"Hematopoiesis":[530]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-08-09T00:00:00"}
